Sign In
Buy EVH
$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Evolent Health (EVH) Q1 Earnings Lag Estimates
07:35pm, Thursday, 08'th May 2025
Evolent Health (EVH) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.34 per share a year ago.
Evolent Announces First Quarter 2025 Results
04:10pm, Thursday, 08'th May 2025
WASHINGTON , May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through
Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade
11:00am, Wednesday, 07'th May 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors
06:30am, Tuesday, 22'nd Apr 2025
Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability. Mr. Guertin's nomination represents continuation of Evolent's board refreshment effort
Evolent program achieves 20% reduction in use of low-value oncology regimens
09:00am, Tuesday, 15'th Apr 2025
Program aims to achieve the best possible treatment outcomes — longer lives with fewer side-effects — without excess financial strain. Collegial provider engagement model brings together education
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025
05:00pm, Thursday, 10'th Apr 2025
Company to Participate in Upcoming Conferences WASHINGTON , April 10, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with comp
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
07:28pm, Thursday, 20'th Feb 2025
Evolent Health, Inc. (NYSE:EVH ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Offi
Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Thursday, 20'th Feb 2025
The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street
Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates
06:40pm, Thursday, 20'th Feb 2025
Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago.
Evolent Announces Fourth Quarter and Full Year 2024 Results
04:10pm, Thursday, 20'th Feb 2025
Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth over 2023, respectively. Net loss
Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Monday, 17'th Feb 2025
Beyond analysts' top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the q
Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline
11:07am, Thursday, 13'th Feb 2025
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Evolent Health Announces Changes to Board of Directors
07:00am, Tuesday, 04'th Feb 2025
Richard " Rick " Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb ' s Appointment as New Independent Director WASHIN
New Strong Sell Stocks for January 30th
04:06am, Thursday, 30'th Jan 2025
DEC, ERO and EVH have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2024.
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025
05:00pm, Monday, 27'th Jan 2025
Company to Participate in Upcoming Conferences WASHINGTON , Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with comple
